Enzyme replacement therapy is not available for which disease?
**Core Concept**
Enzyme replacement therapy (ERT) is a treatment approach that involves administering recombinant enzymes to replace deficient or missing enzymes in patients with genetic disorders. This therapy aims to alleviate symptoms and improve quality of life by supplementing the lack of enzymes responsible for specific metabolic processes.
**Why the Correct Answer is Right**
ERT is available for several diseases, including Gaucher disease, Fabry disease, Pompe disease, and Hunter syndrome, among others. These conditions are caused by deficiencies in specific enzymes, such as glucocerebrosidase, alpha-Gal A, acid alpha-glucosidase, and iduronate-2-sulfatase, respectively. By replacing these deficient enzymes, ERT can help mitigate the disease's progression and associated complications.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because ERT is not specifically mentioned for this disease, but it's worth noting that other treatments, like hematopoietic stem cell transplantation, may be explored.
**Option B:** This option is incorrect because ERT is available for some forms of this disease, although the condition is complex, and treatment may involve multiple approaches.
**Option C:** This option is incorrect because ERT is not currently available for this disease, and other treatments, such as gene therapy, are being investigated.
**Clinical Pearl / High-Yield Fact**
ERT is a highly individualized treatment approach, and the availability of specific therapies can vary widely depending on the disease, enzyme deficiency, and patient characteristics.
**Correct Answer:** C.